Sequential Allocation Study of Music Duration

July 21, 2025 updated by: Tufts Medical Center
The investigators are interested in studying the effects of varying lengths of musical exposure on patient anxiety and stress levels.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In prior studies, anxiety and musical exposure was investigated, but yielded results showing both a decrease in anxiety and increase in anxiety. As such, it is possible that there is a "dose" of musical exposure that would achieve optimal anti-anxiety effects, with decreasing efficacy when undershot or overshot. In previous studies, it has been demonstrated that specific selections of Mozart Sonata's, composed with specific rhythms and modes have helped improve patient anxiety through patient mechanisms. As such, this study will continue to use music described in Conrad's previous studies not only as a control mechanism for exposure, but also utilizing already established principals and groundwork.

Once the subject is recruited, patient demographic data and baseline vital signs (including anxiety levels) will be recorded from the patient charts that have been filled out by the patient's provider. Anxiety assessment will be on a scale of 0-10 and the patient will simply be asked to rate their anxiety on that scale, with 0 being absolutely no anxiety and a 10 being the most anxious they have ever felt.

In the exposure group, an investigator will come in with a stereo music player with external speakers that will have the musical pieces pre-loaded. The investigator will be in charge of setting up the music player and starting the music. The patients will then proceed with their predetermined listening time of music. Upon completion, vital signs (including anxiety levels) will once again be collected by the patient's providers and recorded by the investigator. The investigator will also ask a few questions that assess the patient's experience throughout the study and their experience with listening to and playing musical instruments.

In the control group, an investigator will proceed with a predetermined time of no music. Participants and supporting staff would be asked not to play music in the room during the observed time. Upon completion, vital signs (including anxiety levels) will once again be collected by the patient's providers and recorded by the investigator. The investigator will also ask a few questions that assess the patient's experience throughout the study and their experience with listening to and playing musical instruments.

This study will be performing an Up-Down sequential allocation study using Dixon's method to estimate the minimum dose, which provides a 50% chance of reducing anxiety. Specifically, the investigators will start at a musical exposure of 15 minutes for the first study participant. Upon collecting the first participant's anxiety score post-music exposure, the differences in pre-exposure and post-exposure anxiety scores will be calculated. The second study participant will have their exposure time "stepped up" or increased, by 5 minutes if the first study subject results in a failure, defined as either no change or an increase in their post-exposure anxiety. If there was a decrease in anxiety post-exposure, or a "success", then the second subject will have their exposure time reduced by 5 minutes, or "stepped down". From there, the third participant's exposure time will be adjusted based on the outcomes of the second participant. This method and pattern will be applied for all subsequent participants in order to find the lowest duration of music exposure to achieve an effective dose.

The same Up-Down sequential allocation study method will be utilized for the control group. Specifically, the investigators will start with no-music exposure of 15 minutes for the first study participant. Upon collecting the first participant's anxiety score post-no-music exposure, the differences in pre-exposure and post-exposure anxiety scores will be calculated. The second study participant will have their exposure time "stepped up" or increased, by 5 minutes if the first study subject results in a failure, defined as either no change or an increase in their post-exposure anxiety. If there was a decrease in anxiety post-exposure, or a "success", then the second subject will have their exposure time reduced by 5 minutes, or "stepped down". From there, the third participant's exposure time will be adjusted based on the outcomes of the second participant. This method and pattern will be applied for all subsequent participants in order to find the lowest duration of music exposure to achieve an effective dose.

The absolute minimal musical exposure time will be set at 1 minute and if the effective dose is achieved at 1 minute, the investigators will start each subsequent patient at 1 minute of musical exposure. After the first 5-minute exposure is achieved, from either success or failures, the time increments will be adjusted by increments of 1 minute instead of the previous 5. For example, a failure at 5 minutes will result in the subsequent patient to have an exposure time of 6 minutes, while a success at 5 minutes will result in the subsequent patient to have an exposure time of 4 minutes. The patients in the exposure arm will all listen to Mozart music played for them from a speaker that will be controlled by the investigator. The study will terminate once the investigators achieve 6 "cross overs" between up and down steps or if 30 participants have been recruited-whichever comes first. Statistical analysis and final ED50 determination will be done using methods described by Dixon and Massey.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02111
        • Tufts Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18-50
  • Elective scheduled cesarean delivery
  • Able to provide informed consent

Exclusion Criteria:

  • Patient refusal
  • Impaired hearing
  • Patient taking at least one anti-anxiolytic medication on a daily basis at baseline
  • No anxiety (a score of 0, on a scale of 0-10 of pre-music exposure anxiety) after consent is given.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music Exposure
Patient will listen to a specified duration of music.
Music will be played for participants.
No Intervention: No-Music Exposure
Patient will not listen to music to for specified duration of time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety through a questionnaire rating anxiety levels on a scale of 0-10
Time Frame: baseline and up to 60 minutes after exposure.
Investigators will measure the patient's anxiety pre exposure on a scale of 0-10, with 0 being no anxiety and 10 being extreme anxiety. Anxiety will be assessed again on the same scale post musical exposure.
baseline and up to 60 minutes after exposure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General Musical Experience
Time Frame: Up to 60 minutes after musical exposure

The investigators will ask questions inquiring about the general musical experience for the patient in both the research context and their lives. The questions will include:

  1. Overall, how would you rate your experience listening to music pre-operation on a scale of 0-10, with 1 being the worst experience and 10 being the best experience?
  2. If you were to have another C-section, would you want to listen to music before hand? Definitely Not Maybe Not Maybe Yes Definitely Yes
  3. Would you recommend listening to music before a C-section to friends and family? Definitely Not Maybe Not Maybe Yes Definitely Yes
  4. Would you consider yourself as someone who listens to music regularly for enjoyment? Yes No
  5. What musical experience, if any, do you have?

    1. What level of education do you have in music?
    2. Are you currently active in music?
Up to 60 minutes after musical exposure
Change in Heart Rate between baseline and at end of exposure
Time Frame: baseline and up to 60 minutes after exposure.
The investigators will measure the patient's heart rate before and after musical exposure
baseline and up to 60 minutes after exposure.
Change in Blood Pressure between baseline and at the end of exposure
Time Frame: baseline and up to 60 minutes after exposure.
The investigators will measure the patient's blood pressure before and after musical exposure
baseline and up to 60 minutes after exposure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

May 1, 2025

Study Completion (Actual)

July 1, 2025

Study Registration Dates

First Submitted

May 13, 2021

First Submitted That Met QC Criteria

May 26, 2021

First Posted (Actual)

June 2, 2021

Study Record Updates

Last Update Posted (Actual)

July 24, 2025

Last Update Submitted That Met QC Criteria

July 21, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 00001496

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Music Exposure

Subscribe